Morbidity and mortality in common variable immune deficiency over 4 decades
Authors:
O. Hrodek
Published in:
Transfuze Hematol. dnes,18, 2012, No. 2, p. 88.
Category:
Selection of press reports and books
Labels
Haematology Internal medicine Clinical oncologyArticle was published in
Transfusion and Haematology Today
2012 Issue 2
- Neutralizing Antibodies Against Emicizumab – Detailed Analysis Based on a Case Study
- Position of aPCC in the Treatment of Hemophilia A Complicated by the Development of Inhibitors
- Sport and Physical Activity Benefit Hemophiliacs
- What FVIII Levels Are Ideal for Preventing Bleeding in Hemophilia A?
- Administration of aPCC as a Prevention of Bleeding After Major Cardiac Surgical Procedures
Most read in this issue
- Current possibilities of laboratory diagnosis heparin-induced trombocytopenia
- n 18-year old Female with a History of Collapse – Case Report
- Significance of hepcidin level assessment in the diagnosis of selected types of anaemia in childhood
- Early molecular response evaluation after 3 months of imatinib therapy in patients with chronic myeloid leukemia can contribute to estimation of prognosis – single centre experience